Risk factors for long-term prognosis of hepatocellular carcinoma patients after anatomic hepatectomy

Table 1 Baseline characteristics of study participants (n = 74)

Category	Numbers of patients	1 (yr)		3 (yr)
		χ2	P	χ2	P
Age, yr		0.732	0.694	0.56	0.756
≤ 60	42
> 60	32
Sex		0.037	0.848	0.352	0.553
Male	54
Female	20
Diabetes		0.073	0.788	3.044	0.081
Yes	12
No	62
Hypertension		0.021	0.883	0.099	0.754
Yes	23
No	51
Hepatic cirrhosis		3.653	0.056	8.864	0.003
Yes	33
No	41
Jaundice		10.610	0.001	12.118	0.0001
Yes	18
No	56
Portal vein tumor thrombus		1.602	0.206	0.749	0.387
Yes	7
No	67
Maximal tumor diameter, cm		8.325	0.004	5.111	0.024
≤ 5	41
> 5	33
Tumor number		1.754	0.185	0.134	0.715
Single	58
At least two	16
Tumor stage		22.402	0.0001	25.982	0.0001
1	30
2	15
3	14
4	15
BCLC stage		0.265	0.607	0.125	0.724
0	51
A	23
Alpha-fetoprotein, ng/mL		0.412	0.521	0.035	0.851
≤ 400	62
> 400	12
Albumin, g		0.053	0.818	1.004	0.316
≤ 35	8
> 35	66
AST, U/L		0.487	0.485	0.868	0.351
≤ 80	67
> 80	7

BCLC: Barcelona clinic liver cancer; AST: Aspartate aminotransferase.